Michael Chang joined Vivo with a background in healthcare strategy and operations in both the U.S. and China. Prior to Vivo, he worked at Johnson & Johnson, where he helped establish the strategy and commercial planning function for J&J’s China medical device business. Previously, he worked for Booz & Company and Fletcher Spaght, and also co-founded a company in the vascular access space.
Michael graduated from Harvard University with a B.A. in Economics, with a focus on health policy, and an M.B.A. from Harvard Business School. He also has research experience at Harvard Medical School and University of California Irvine in brain tumor immunology and cancer genetics.